检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王寒 WANG Han(Shenyang Huanggu District Health Service and Administrative Law Enforcement Center,Women and Children Center,Shenyang 110031,China)
机构地区:[1]辽宁省沈阳市皇姑区卫生健康服务与行政执法中心,妇幼中心,辽宁沈阳110031
出 处:《中国医药指南》2020年第36期133-134,共2页Guide of China Medicine
摘 要:目的探讨布地奈德混悬液喷射雾化吸入与超声雾化吸入在耳鼻喉科疾病中的应用效果,以便为耳鼻喉科疾病的治疗提供科学依据。方法选取2017年12月至2019年12月医院门诊检查治疗的80例耳鼻喉科疾病患者作为试验组,给予布地奈德混悬液喷射雾化治疗;选取同期80例耳鼻喉科疾病患者作为对照组,给予超声雾化吸入治疗。对比两组患者的治疗效果。结果试验组治疗总有效率显著高于对照组,差异有统计学意义(P<0.05)。试验组不良反应发生率显著低于对照组,差异有统计学意义(P<0.05)。结论在耳鼻喉科疾病患者中采用布地奈德混悬液喷射雾化吸入治疗的效果更显著,不良反应更少,具有较高的安全性与可靠性。Objective To investigate the application effect of budesonide suspension spray atomization and ultrasonic atomization inhalation in otolaryngology diseases,in order to provide scientific basis for the treatment of otolaryngology diseases.Methods Eighty patients with otolaryngological diseases who were examined and treated in the outpatient department of the hospital from December 2017 to December 2019 were selected as the experimental group and given budesonide suspension injection atomization treatment.Eighty patients with otolaryngology diseases were selected as the control group and given ultrasonic atomization inhalation treatment.The therapeutic effect of the two groups was compared.Results The total effective rate of experimental group was significantly higher than that of control group,with statistical significance(P<0.05).The incidence of ADR in experimental group was significantly lower than that in control group,with statistical significance(P<0.05).Conclusion In patients with otolaryngology diseases,budesonide suspension injection aerosol inhalation treatment has a more significant effect,less adverse reactions,with high safety and reliability.
关 键 词:耳鼻喉科疾病 雾化吸入治疗 布地奈德混悬液喷射雾化吸入 超声雾化吸入
分 类 号:R76[医药卫生—耳鼻咽喉科]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.144.143.110